Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on copyright Use Disorder
copyright use disorder (CUD) is a major public health challenge with a high relapse rate and lack of effective pharmacotherapies; therefore, there is a substantial need to identify novel medications to treat this epidemic.Since the advent of glucagon-like peptide-1 (GLP-1) receptors (GLP-1Rs) agonists (GLP-1RAs), their potential has been extensivel